Understanding Persistent Pulmonary Hypertension of the Newborn (PPHN)
Dr. Shyamala Dakshinamurti and her team are preparing for new testing that will bring them one step closer to understanding Persistent Pulmonary Hypertension of the Newborn (PPHN), the potentially fatal condition that occurs when a baby’s lungs fail to make a smooth transition from life in the womb.
Five years ago, Dakshinamurti and her research team became the first in the world to discover that the problem may be caused by the shutdown of a “gatekeeper” molecule in an infant’s lung.
Now, Dr. Shyamala Dakshinamurti and her team are preparing to test several variations of a compound that may be able to get the molecule working properly.
Wave Magazine recently featured Dr. Shyamala Dakshinamurti and her team. Read the full article here.
Because of donors like you…
Through the Children’s Hospital Research Institute of Manitoba, founded by the Foundation in 2001, you help scientists work together to unlock the mysteries of childhood diseases. You give hope to families. You help move child health care forward. You are the power behind medical breakthroughs.